BIGG

AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity

Grunvald, Eduardo; Shah, Raj; Hernaez, Ruben; Chander, Apoorva Krishna; Teigen, Levi M; Sultan, Shahnaz; Sigh, Siddarth; Daviikov, Perica.

Gastroenterology; 163 (5), 2022

Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...

Factores de Riesgo de Enfermedad Cardiaca, Resistencia a la Insulina, Obesidad/tratamiento farmacológico, Depresores del Apetito, Hipoglucemiantes/uso terapéutico, Diabetes Mellitus Tipo 2/prevención & control, Topiramato/uso terapéutico, Fármacos Antiobesidad/uso terapéutico

Texto completo

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline

Martin, KA; Anderson, RR; Chang, RJ; Ehrmann, DA; Lobo, RA; Murad, MH; Pugeat, MM; Rosenfield, RL.

J. clin. endocrinol. metab; 103 (4), 2018

Antagonistas de Andrógenos/uso terapéutico, Anticonceptivos Orales Combinados/uso terapéutico, Hipoglucemiantes/uso terapéutico, Remoción del Cabello/métodos, Hirsutismo/diagnóstico, Premenopausia, Índice de Severidad de la Enfermedad, Hirsutismo/terapia

Texto completo

Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus

World Health Organization.

Diabetes is a chronic, progressive disease characterized by elevated blood glucose levels. Diabetes can lead to complications such as cardiovascular disease, damage to eyes, kidneys and nerves, and premature death. Globally, more than 400 million adults live with diabetes, and diabetes directly caused 1....

Insulina/uso terapéutico, Control Glucémico, Diabetes Mellitus Tipo 2/prevención & control, Hipoglucemiantes/uso terapéutico

Texto completo

VA/DoD clinical practice guideline for the management of type 2 diabetes mellitus in primary care

U.S. Department of Veterans Affairs.

DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...

Diabetes Mellitus Tipo 2, Diabetes Mellitus, Biomarcadores/sangre, Glucemia/metabolismo, Angiopatías Diabéticas/prevención & control, Fructosamina/sangre, Hemoglobina Glucada/metabolismo, Hipoglucemiantes/uso terapéutico, Esperanza de Vida, Prioridad del Paciente, Atención Dirigida al Paciente, Hemoglobina Glucada, Hipoglucemiantes

Texto completo (enlace principal) Texto completo (enlace alternativo)

Guía de práctica clítica tratamiento farmacológico de la diabetes mellitus tipo 2

Chile. Ministerio de Salud. Gobierno de Chile.

Entregar recomendaciones para apoyar a los equipos de salud en la toma de decisiones clínicas respecto del tratamiento farmacológico en pacientes adultos con diagnóstico de Diabetes Mellitus tipo 2, basadas en la mejor evidencia científica disponible y el consenso de expertos....

Diabetes Mellitus Tipo 2/diagnóstico, Diabetes Mellitus Tipo 2/tratamiento farmacológico, Hipoglucemiantes/uso terapéutico

Texto completo

Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

Peters, AL; Ahmann, AJ; Battelino, T; Evert, A; Hirsch, IB; Murad, MH; Winter, WE; Wolpert, H.

J. clin. endocrinol. metab; 101 (11), 2016

"OBJECTIVE: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. PARTICIPANTS: The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...

Texto completo